HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
37 hedge funds and large institutions have $11.9M invested in Hepion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
14
Closed
10
Calls
$1.53M
Puts
$409K
Net Calls
+$1.12M
Net Calls Change
+$1.08M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$68.8K |
| 2 |
AMC
Asset Management Corp
Northbrook,
Illinois
|
+$63.9K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$60K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$47.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$38.5K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.24M |
| 2 |
Two Sigma Advisers
New York
|
-$1.14M |
| 3 |
ACM
Altium Capital Management
New York
|
-$883K |
| 4 |
Two Sigma Investments
New York
|
-$485K |
| 5 |
VF
Virtu Financial
New York
|
-$225K |
